Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 459

1.

The IL-10 and IFN-gamma pathways are essential to the potent immunosuppressive activity of cultured CD8+ NKT-like cells.

Zhou L, Wang H, Zhong X, Jin Y, Mi QS, Sharma A, McIndoe RA, Garge N, Podolsky R, She JX.

Genome Biol. 2008;9(7):R119. doi: 10.1186/gb-2008-9-7-r119. Epub 2008 Jul 29.

PMID:
18664279
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells.

Shi Z, Rifa'i M, Lee YH, Shiku H, Isobe K, Suzuki H.

Immunology. 2008 May;124(1):121-8. doi: 10.1111/j.1365-2567.2007.02747.x. Epub 2008 Jan 16.

PMID:
18205792
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.

Bochtler P, Kröger A, Schirmbeck R, Reimann J.

J Immunol. 2008 Aug 1;181(3):1633-43.

PMID:
18641299
[PubMed - indexed for MEDLINE]
Free Article
4.

Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.

Stremmel C, Exley M, Balk S, Hohenberger W, Kuchroo VK.

Eur J Immunol. 2001 Sep;31(9):2818-28.

PMID:
11536181
[PubMed - indexed for MEDLINE]
5.

Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells.

Gansuvd B, Hubbard WJ, Hutchings A, Thomas FT, Goodwin J, Wilson SB, Exley MA, Thomas JM.

J Immunol. 2003 Sep 15;171(6):2904-11.

PMID:
12960313
[PubMed - indexed for MEDLINE]
Free Article
6.

AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.

Kosaka A, Wakita D, Matsubara N, Togashi Y, Nishimura S, Kitamura H, Nishimura T.

Int Immunol. 2007 Mar;19(3):249-56. Epub 2007 Jan 17.

PMID:
17229818
[PubMed - indexed for MEDLINE]
Free Article
8.

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.

Baker J, Verneris MR, Ito M, Shizuru JA, Negrin RS.

Blood. 2001 May 15;97(10):2923-31.

PMID:
11342413
[PubMed - indexed for MEDLINE]
Free Article
9.

Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.

Wahl C, Bochtler P, Schirmbeck R, Reimann J.

J Immunol. 2007 Feb 15;178(4):2083-93.

PMID:
17277112
[PubMed - indexed for MEDLINE]
Free Article
10.

Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells.

Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier LL, Liu YJ.

J Exp Med. 2001 May 21;193(10):1221-6.

PMID:
11369793
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils.

Hwang SJ, Kim S, Park WS, Chung DH.

J Immunol. 2006 Oct 15;177(8):5258-68.

PMID:
17015711
[PubMed - indexed for MEDLINE]
Free Article
12.

In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.

Baxevanis CN, Gritzapis AD, Papamichail M.

J Immunol. 2003 Sep 15;171(6):2953-9.

PMID:
12960319
[PubMed - indexed for MEDLINE]
Free Article
13.

Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naïve CD8+ T cells in the mouse.

Dikopoulos N, Wegenka U, Kröger A, Hauser H, Schirmbeck R, Reimann J.

Hepatology. 2004 May;39(5):1256-66.

PMID:
15122754
[PubMed - indexed for MEDLINE]
14.

Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.

Trobonjaca Z, Leithäuser F, Möller P, Schirmbeck R, Reimann J.

J Immunol. 2001 Aug 1;167(3):1413-22.

PMID:
11466360
[PubMed - indexed for MEDLINE]
Free Article
15.

Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells.

Endharti AT, Rifa'I M, Shi Z, Fukuoka Y, Nakahara Y, Kawamoto Y, Takeda K, Isobe K, Suzuki H.

J Immunol. 2005 Dec 1;175(11):7093-7.

PMID:
16301610
[PubMed - indexed for MEDLINE]
Free Article
16.

CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.

Ueda N, Kuki H, Kamimura D, Sawa S, Seino K, Tashiro T, Fushuku K, Taniguchi M, Hirano T, Murakami M.

Int Immunol. 2006 Sep;18(9):1397-404. Epub 2006 Aug 16.

PMID:
16914507
[PubMed - indexed for MEDLINE]
Free Article
17.

NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye.

Sonoda KH, Nakamura T, Young HA, Hart D, Carmeliet P, Stein-Streilein J.

J Immunol. 2007 Aug 15;179(4):2215-22.

PMID:
17675481
[PubMed - indexed for MEDLINE]
Free Article
18.

Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.

Togashi Y, Chamoto K, Wakita D, Tsutsumi N, Iwakura Y, Matsubara N, Kitamura H, Nishimura T.

Cancer Sci. 2007 May;98(5):721-5. Epub 2007 Mar 14.

PMID:
17359285
[PubMed - indexed for MEDLINE]
19.

Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.

Margalit M, Shibolet O, Klein A, Elinav E, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Int J Cancer. 2005 Jun 20;115(3):443-9.

PMID:
15688366
[PubMed - indexed for MEDLINE]
20.

Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.

Stenström M, Sköld M, Ericsson A, Beaudoin L, Sidobre S, Kronenberg M, Lehuen A, Cardell S.

Eur J Immunol. 2004 Jan;34(1):56-65.

PMID:
14971030
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk